Skip to main content
AVANOS MEDICAL, INC. logo

AVANOS MEDICAL, INC. — Investor Relations & Filings

Ticker · AVNS ISIN · US40650V1008 LEI · 549300YCXWOM7NEWMQ58 US Manufacturing
Open in API
Filings indexed 673 across all filing types
Latest filing 2021-01-06 Director's Dealing
Country US United States of America
Listing US AVNS

About AVANOS MEDICAL, INC.

https://avanos.com/

Avanos Medical, Inc. is a medical technology company that develops, manufactures, and markets medical device solutions. The company's portfolio is focused on two primary segments: Pain Management & Recovery and Enteral Feeding. The Pain Management & Recovery division provides a range of non-opioid therapies and solutions for managing chronic and post-surgical pain, targeting specialties such as anesthesiology, orthopedics, and interventional pain management. The Enteral Feeding division offers a comprehensive portfolio of nutrition delivery systems and products for a wide spectrum of patients, from neonates and pediatrics to adults, supporting healthcare providers in critical and long-term care settings. The company is focused on delivering clinically superior solutions that improve patient outcomes and facilitate recovery.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2021-01-06 English
FORM 4
Director's Dealing
2021-01-06 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. There is no indication of the document being a report itself or an announcement of a report. Due to the lack of identifiable information and the fallback rule for documents that do not fit any specific category, the appropriate classification is Regulatory Filings (RNS). The document length is 15,000 characters, which is substantial, but without meaningful content, it cannot be classified as a financial or other specific report type.
2021-01-05 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a letter from Avanos Medical, Inc. to the SEC responding to comments from the SEC staff regarding the company's previously filed Form 10-K for the fiscal year ended December 31, 2019. The letter addresses specific SEC staff comments about the company's forum selection provision and exhibits filing compliance. It does not contain the actual 10-K report or financial statements but is a correspondence related to regulatory review of the 10-K filing. The document length is about 5975 characters, which is relatively short and consistent with a comment response letter rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory correspondence and compliance documents that do not fit other categories.
2020-12-18 English
FORM 4
Director's Dealing
2020-12-08 English
Regulatory Filings 2020
Regulatory Filings Classification · 90% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. There is no indication of the document being a report itself or an announcement of a report. Given the lack of discernible information and the fallback rule for documents that do not fit any specific category, the appropriate classification is Regulatory Filings (RNS). The document length is 15,000 characters, which is substantial, but without readable content, it cannot be classified as a financial or other specific report type.
2020-12-07 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.